Newest (3rd) production facility Yumen Plant going to boost #s together with latest 'deal' (MOU) with Guangdong Jiangwang International Holdings Limited (“Jiangwang”). This MOU allows the parties to negotiate the terms and conditions of a definitive agreement for $BON to distribute Jiangwang’s Chinese White Spirits (“Spirits”) and other related health products in China Markets. >>> News pending imo. $BON $$$$$$$
$BON >>> Bon Natural Life (BON) Regains Nasdaq Compliance
Corporate News (October 12, 2023 12:58 PM EDT)
On June 30, 2023, Bon Natural Life (NASDAQ: BON) received a letter from Nasdaq Stock Market, LLC, notifying the Company that it no longer complied with Nasdaq’s majority independent board and independent audit, compensation, and nominating committee requirements as set forth in Listing Rule 5605. As disclosed in its Report on Form 6-K filed with the SEC on August 4, 2023, the Company appointed Jianjun Gao, Ph.D. as a new independent director on August 2, 2023. As disclosed in its Report on Form 6-K filed with the SEC on October 5, 2023, the Company appointed Jing Chen and Zhixiang Gao as additional independent directors on October 2, 2023.
On October 9, 2023, the Company received notification from Nasdaq that it has regained compliance with Listing Rule 5605.
$TOPS >>> LAX Trust gobbled up 3% more shares in a week. They might be going private soon? Stake increased from 59% to close to 62%.
Those $AULT #s are out of date, bro.
Total Assets as of 30th June 2023: 378M (Down from 611M back in Q3 2022)
Total Debts as of 30th June 2023: 279M (Up from 152M back in Q2 2022)
Net Income last 3 Qs:
Q2 2023: (-60,683,000)
Q1 2023: (-48,646,000)
Q4 2022: (-120,009,000)
Shares Outstanding: 10.58M
Profit Margin: -145.39%
Operating Margin (ttm): -42.53%
Return on Assets (ttm): -8.88%
Return on Equity (ttm): -84.69%
Net Income Avi to Common (ttm): -236.72M
Diluted EPS (ttm): -197.98
Btw I'm expecting further big losses in Q3 & Q4 2023. Jmo. *NFA
Perhaps better have a look at $GLG? Cud be the next big runner from down here @.1248!?
(#s look way better over there.)
The Wall Street Journal
RVL Pharmaceuticals Subsidiaries File for Bankruptcy
by Will Feuer
Thu, October 12, 2023 at 2:31 PM GMT+2
"(..) As a result of the Reorganization, RVL is expected to commence the wind-down of any remaining operations of the Company and its subsidiaries, other than the RVL Subsidiaries. RVL’s public equity is expected to be cancelled upon completion of its wind-down, anticipated to be during 2024, likely resulting in no recovery to public shareholders. (..)"